Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/57930
Título: Eficacia de florfenicol para el tratamiento de infeciones por Pasteurela Multocida y Mannheimia Haemolitica en llamas
Título(s) alternativo(s): Eficacy of florfenicol for the treatment of infections by Pasteurella Multocida and Mannheimia Haemolitica in llamas
Palavras-chave: Pharmacokinetic / pharmacodynamicmodeling
Lama glama
South American camelids
Modelamento farmacocientico/farmacodinâmico
Camelidos sudamericanos
Data do documento: 2018
Editor: Centro Científico Conhecer
Citação: FERRANTE, M. Eficacia de florfenicol para el tratamiento de infeciones por Pasteurela Multocida y Mannheimia Haemolitica en llamas. Enciclopédia Biosfera, Goiânia, v.15 n. 28, 2018.
Resumo: Florfenicol is one of the main antibiotics used in the therapy of bacterial respiratory infections in the clinic of large animals. However, there are no pharmacokinetic / pharmacodynamic (PK/PD) studies evaluating its efficacy in llamas antibiotic therapy. The objective of the present study is to evaluate the effect of treatment of intramuscular 20 mg/kg dose of florfenicol in the treatment of infections caused by P. multocida and M. Haemolitica in llamas. A Monte Carlo simulation was performed to determine efficacy rates. The estimated efficacy rates for P. multocida were 99%; 20% and 1% and according to MICs of strains 0.5; 1 and 2 respectively. While the estimated efficacy rates for M. haemolitica were 100%, 95% and 3% and accordingto MICs of strains 0.5, 1 and 2 respectively. The probability of obtaining the bacteriological cure after treatment decreased significantly for infections caused by bacteria with MICs greater than 0.5ug / ml for P. multocida (p˂0,01) and 1 ug/ml for M. haemolitica (p˂0,01). These results evidenced the need to incorporate in the therapeutic protocol bacteriological isolation, determination of MIC and therapeutic dose optimization according to the susceptibility of strains of P. multocida and M. Haemolitica in order to avoid therapeutic failures and consequently to enhance the development of Bacterial resistance.
URI: http://www.conhecer.org.br/enciclop/2018B/AGRAR/eficacia.pdf
http://repositorio.ufla.br/jspui/handle/1/57930
Aparece nas coleções:DMV - Artigos publicados em periódicos

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.